Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

New forum highlights the growing mental health crisis among youth

Half of all lifetime mental illness begins by age 14, with one in five children affected by mental illness and often not getting treatment for years.

4 Jun 2014

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Janssen-Cilag International NV announced today that the European Commission has approved an extension of the oral atypical antipsychotic INVEGA® (paliperidone ER) schizophrenia indication, to include adolescents aged 15 years and older.

4 Jun 2014

Researchers reveal potential new drug target for dementia

Researchers at King's College London have discovered how a molecular 'scaffold' which allows key parts of cells to interact, comes apart in dementia and motor neuron disease, revealing a potential new target for drug discovery.

4 Jun 2014

Exposure to elevated levels of steroid hormones in the womb linked to later development of autism

Scientists from the University of Cambridge and the Statens Serum Institute in Copenhagen, Denmark have discovered that children who later develop autism are exposed to elevated levels of steroid hormones (for example testosterone, progesterone and cortisol) in the womb. The finding may help explain why autism is more common in males than females, but should not be used to screen for the condition.

3 Jun 2014

Usage of marijuana impairs quality of sleep

A new study suggests that marijuana use is associated with impaired sleep quality.

3 Jun 2014

Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

1 in 2 hypertensive pregnant women who habitually snore may have unrecognized obstructive sleep apnea, a sleeping disorder that can reduce blood oxygen levels during the night and that has been linked to serious health conditions, new University of Michigan-led research shows.

3 Jun 2014

Study suggests that circadian factors may contribute to suicidality

A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.

3 Jun 2014

NYU Langone scientists identify promising treatment target for Alzheimer's disease

Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer's disease.

3 Jun 2014

Study: Use of antipsychotic medication during pregnancy can affect babies

A seven-year study of women who take antipsychotic medication while pregnant, proves it can affect babies.

3 Jun 2014

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals plc today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a potential new treatment for the symptoms of excessive daytime sleepiness (EDS) in adults with narcolepsy.

3 Jun 2014

Research roundup: End-of-life preferences; surviving trauma when older; ACA's big waiver for states

Policies and practices that promote advance care planning and advance directive completion implicitly assume that patients' choices for end-of-life (EOL) care are stable over time, even with changes in health status.

31 May 2014

Northwestern Medicine allergist offers tips to fight allergies

Nasal congestion, sneezing, and itchy and watery eyes — for the nearly 50 million Americans with seasonal allergies, these are the true rites of spring

31 May 2014

People affected by disorders of compulsivity share common pattern of decision making and brain structure

People affected by binge eating, substance abuse and obsessive compulsive disorder all share a common pattern of decision making and similarities in brain structure, according to new research from the University of Cambridge.

30 May 2014

Sudden loss of loved one can trigger psychiatric disorders in people with no history of mental illness

The sudden loss of a loved one can trigger a variety of psychiatric disorders in people with no history of mental illness, according to researchers at Columbia University's Mailman School of Public Health and colleagues at Columbia's School of Social Work and Harvard Medical School.

30 May 2014

New powerful tool helps identify disease-causing mutations in families

Scientists at the University of Utah (U of U), the University of Texas MD Anderson Cancer Center in Houston and colleagues have developed a powerful tool called pVAAST that combines linkage analysis with case control association to help researchers and clinicians identify disease-causing mutations in families faster and more precisely than ever before.

30 May 2014

Tackling ambivalence helps psychosis patients back into work

Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.

29 May 2014

Allowing PTSD patients to choose their own treatment is less expensive, shows study

A cost-analysis of post-traumatic stress disorder treatments shows that letting patients choose their course of treatment - either psychotherapy or medication - is less expensive than assigning a treatment and provides a higher quality of life for patients.

29 May 2014

Study defines specific genetic mechanism that explains some of schizophrenia's heritability

The overall number and nature of mutations—rather than the presence of any single mutation—influences an individual's risk of developing schizophrenia, as well as its severity, according to a discovery by Columbia University Medical Center researchers published in the latest issue of Neuron.

29 May 2014

Monday blues, weekend highs for bipolar patients

Psychosocial factors cause weekly cycles in the mood and functional impairment of patients with bipolar disorder, independent of their medication use, say researchers.

28 May 2014

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).

28 May 2014

Psychiatry News and Research

Further Reading

New forum highlights the growing mental health crisis among youth

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Researchers reveal potential new drug target for dementia

Exposure to elevated levels of steroid hormones in the womb linked to later development of autism

Usage of marijuana impairs quality of sleep

Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

Study suggests that circadian factors may contribute to suicidality

NYU Langone scientists identify promising treatment target for Alzheimer's disease

Study: Use of antipsychotic medication during pregnancy can affect babies

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Research roundup: End-of-life preferences; surviving trauma when older; ACA's big waiver for states

Northwestern Medicine allergist offers tips to fight allergies

People affected by disorders of compulsivity share common pattern of decision making and brain structure

Sudden loss of loved one can trigger psychiatric disorders in people with no history of mental illness

New powerful tool helps identify disease-causing mutations in families

Tackling ambivalence helps psychosis patients back into work

Allowing PTSD patients to choose their own treatment is less expensive, shows study

Study defines specific genetic mechanism that explains some of schizophrenia's heritability

Monday blues, weekend highs for bipolar patients

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News